Evidence map›Paper›PMID 29042794›Full record

ReviewOncoTargets and therapy2017

Comparison of microwave ablation and hepatic resection for hepatocellular carcinoma: a meta-analysis.

Manka Zhang, Huimin Ma, Jian Zhang, Lingling He, Xiaohui Ye, Xin Li

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in OncoTargets and therapy, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 2 pooled it
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 2 syntheses or guidelines pooled it, 61 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Percutaneous microwave ablation of hepatic lesions near the heart.Translational gastroenterology and hepatology · 2021
    Article
  16. Treatment Options for Early-Stage Hepatocellular Carcinoma.Seminars in interventional radiology · 2020
    Review
  17. Review
  18. Article
  19. Microwave ablationTherapeutic advances in medical oncology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Manka ZhangDepartment of Center of Integrated Traditional Chinese and Western Medicine, Peking University Ditan Teaching Hospital.
Huimin MaDepartment of Center of Integrated Traditional Chinese and Western Medicine, Beijing Ditan Hospital, Capital Medical University.
Jian ZhangDepartment of Center of Integrated Traditional Chinese and Western Medicine, Peking University Ditan Teaching Hospital.
Lingling HeDepartment of Institute of Infectious Disease, Beijing Ditan Hospital, Capital Medical University.
Xiaohui YeDepartment of Institute of Infectious Disease, Peking University Ditan Teaching Hospital, Beijing, People's Republic of China.
Xin LiDepartment of Center of Integrated Traditional Chinese and Western Medicine, Peking University Ditan Teaching Hospital.
King University · USCapital Medical University · CNPeking University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

aimsHepatic resection (HRN) and microwave ablation (MWA) have significant advantages in treating hepatocellular carcinoma; however, it remains unclear which way produces better outcomes. This meta-analysis of cohort studies compared the treatments in terms of effectiveness and safety.

methodsSix electronic databases (PubMed, Medline, EMBASE, Web of Science, EBSCO, and The Cochrane Library) were retrieved for studies comparing MWA and HRN. The meta-analysis was conducted based on statement of preferred reporting items for systematic reviews and meta-analyses.

resultsNine studies met the inclusion criteria, with a total of 1,480 patients. The overall meta-analysis demonstrated no significant difference in overall survival between the MWA group and the HRN group (HR =0.98, 95% CI =0.76-1.26,

conclusionIn conclusion, our meta-analysis suggests that MWA may be superior to HRN as it is as effective as HRN in terms of overall survival, disease-free survival, tumor recurrence, and is associated with shorter operation time, less amount of blood loss, and fewer complications.

Indexed as

hepatic resectionmicrowave ablationprimary hepatic carcinomasurvival analysis

Identifiers

PMID29042794
PMCPMC5633279
OpenAlexW2761644862

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.